Profit and Loss
| Solara Active Pharma Sciences Ltd Industry: (Pharmaceuticals - Indian - Bulk Drugs & Formln) |
|---|
|
BSE Code:
541540
ISIN Demat:
INE624Z01016
Book Value(₹): 259.51 NSE Symbol:
SOLARA
Div & Yield(%):
N.A
Market Cap(₹ Cr): 3,168.18 P/E(TTM): N.A
EPS(TTM):
1.05
Face Value(₹): 10.00 |
| Dec 26 (₹ Cr) | Dec 25 (₹ Cr) | Dec 24 (₹ Cr) | Dec 23 (₹ Cr) | Dec 22 (₹ Cr) | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,368.98 | 1,283.76 | 1,288.92 | 1,443.81 | 1,268.34 |
| Other Income | 5.89 | 9.14 | 5.37 | 22.14 | 18.76 |
| Stock Adjustments | -8.25 | -39.00 | -39.27 | -7.05 | 258.75 |
| Total Income | 1,366.62 | 1,253.90 | 1,255.02 | 1,458.90 | 1,545.85 |
| EXPENDITURE : | |||||
| Raw Materials | 676.26 | 587.41 | 765.75 | 781.78 | 912.64 |
| Power and Fuel Cost | 98.47 | 94.37 | 122.56 | 107.95 | 93.70 |
| Other Manufacturing Expenses | 92.81 | 67.80 | 109.31 | 90.76 | 97.87 |
| Selling and Administration Expenses | 64.48 | 59.10 | 70.40 | 67.50 | 76.39 |
| Miscellaneous Expenses | 28.72 | 20.56 | 222.41 | 26.68 | 35.43 |
| Employee Benefit Expenses | 223.80 | 214.75 | 246.57 | 228.05 | 234.20 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 186.68 | 212.98 | -279.33 | 156.18 | 95.62 |
| Interest | 94.24 | 114.81 | 105.97 | 90.06 | 75.27 |
| Gross Profit | 92.44 | 98.17 | -385.30 | 66.12 | 20.35 |
| Depreciation | 99.68 | 99.25 | 103.03 | 110.90 | 112.01 |
| Profit Before Tax | -7.24 | -1.08 | -488.33 | -44.78 | -91.66 |
| Current Tax | 0.00 | 0.00 | 0.00 | -0.11 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 78.54 | -22.46 | -33.10 |
| Reported Net Profit | -7.24 | -1.08 | -566.87 | -22.21 | -58.56 |
| Extraordinary Items | -5.89 | 0.00 | -158.84 | -0.45 | -4.26 |
| Adjusted Net Profit | -1.35 | -1.08 | -408.03 | -21.76 | -54.30 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.56 | -1.76 | 2.01 |
| Profit/Loss Balance carried down | -296.16 | -295.37 | 250.04 | 274.01 | 341.34 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | -0.44 | -0.29 | 0.00 | 0.00 | 10.78 |
| P & L Balance carried down | -302.96 | -296.16 | -316.27 | 250.04 | 274.01 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 30.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 3.00 | 0.00 |
| Earnings Per Share-Unit Curr | -1.63 | -0.27 | -157.46 | -6.17 | -16.27 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 282.06 | 272.35 | 260.39 | 417.54 | 424.18 |
| Book Value(Adj)-Unit Curr | 282.06 | 272.35 | 239.98 | 384.83 | 390.94 |